Drugs / BCG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07000084 | Jul 2025 → Jun 2028 expected | non-invasive bladder urothelial carcinoma | Alliance for Clinical Trials in Oncology | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07000084 ↗ |
| Known as | Bacillus Calmette Guerin Solution | “Bacillus Calmette Guerin Solution” NCT07000084 ↗ |
| Route | Other | “Given intravesically” NCT07000084 ↗ |